The other study focused on the role of SNPs in MMR genes (MLH1, MSH2 and MGMT) in melanoma patients after temozolomide and dacarbazine treatment, including comparison with five melanoma cell lines [160]. The gene discussed is MSH2; the disease is melanoma.